Date published: 2026-8-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

Integrin β1/ITGB1 CRISPR/Cas9 KO Plasmid (m): sc-421171

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: mouse
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • Integrin β1/ITGB1 CRISPR/Cas9 Knockout (KO) Plasmid (m) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
  • gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the Integrin β1/ITGB1 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
  • Integrin β1/ITGB1 HDR Plasmid (m) (sc-421171-HDR) is recommended for co-transfection with Integrin β1/ITGB1 CRISPR/Cas9 KO Plasmid (m) to enable selection of successfully edited cells through HDR-mediated integration of a puromycin resistance cassette and RFP reporter gene
  • Integrin β1/ITGB1 HDR Plasmid (m) is a pool of plasmids, each containing a homology-directed repair (HDR) template corresponding to the gRNA target sites in the Integrin β1/ITGB1 CRISPR/Cas9 KO Plasmid (m)
  • Each HDR plasmid contains two ~800 bp homology arms flanking the puromycin resistance and RFP cassettes, designed to bind genomic DNA sequences surrounding the Cas9-induced double-strand break site and facilitate precise HDR-mediated integration
  • The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Integrin β1/ITGB1 Antibody (A-4): sc-374429
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    Integrin β1/ITGB1 CRISPR/Cas9 KO Plasmid (m)

    sc-421171
    20 µg
    $397.00

    Integrin β1/ITGB1 HDR Plasmid (m)

    sc-421171-HDR
    20 µg
    $445.00

    Overview

    Mouse Itgb1 encodes integrin β1 (ITGB1), a core adhesion receptor subunit that heterodimerizes with multiple α integrins to mediate binding to extracellular matrix ligands such as fibronectin, laminins, and collagens. ITGB1 couples outside-in and inside-out signaling to focal adhesion assembly and actin cytoskeleton remodeling, coordinating processes including cell migration, polarity, mechanotransduction, and survival. Through interactions with talin/kindlin and downstream FAK/SRC, PI3K–AKT, MAPK, and Rho GTPase pathways, ITGB1 influences proliferation and differentiation across many tissues. Dysregulated integrin β1 signaling and trafficking are widely studied in contexts of inflammation, fibrosis, and tumor cell invasion/metastasis, making Itgb1 a central node for adhesion-dependent signaling research in mouse models.

    Integrin β1/ITGB1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Itgb1 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Itgb1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.

    When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.

    Homology-Directed Repair (HDR) Donor — Puromycin Cassette with RFP Reporter

    For applications requiring confirmed, selectable knockout clones, Integrin β1/ITGB1 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Itgb1 target site.
    When co-transfected with Integrin β1/ITGB1 CRISPR/Cas9 KO Plasmid (m):

    • The PuroR-RFP cassette integrates at the Cas9 cut site via HDR, disrupting the Itgb1 open reading frame.
    • RFP fluorescence provides an immediate visual indicator of successful integration, enabling fluorescence-based identification or sorting of edited cells prior to or alongside puromycin selection.
    • Successfully edited cells are confirmed through puromycin resistance, substantially reducing clone screening burden.
    • This selection strategy is ideal for generating stable, clonal KO cell lines for downstream functional studies, drug screening, or model development.

    Cre-lox Cassette Removal System

    The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Itgb1 locus and eliminating potential confounding effects on downstream assays.
    This two-step approach:

    • Minimizes disruption to local chromatin architecture and neighboring regulatory elements
    • Restores a near-native genomic context at the edited locus
    • Enables reuse of the puromycin selection strategy in the same cell line for additional edits

    Key Features

    • gRNA targeting Itgb1 exon(s) critical for Integrin β1/ITGB1 function
    • Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
    • HDR donor with puromycin resistance for positive clone selection
    • loxP-flanked PuroR cassette with Cre recombinase vector for seamless marker removal
    • Supplied ready to use for delivery by transfection

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.